Nuveen Credit Strategies Income Fund (JQC) At $8.02 Forms Bottom; Profile of 4 Analysts Covering OraSure Technologies, Inc. (OSUR)

March 13, 2018 - By Annabelle Johnson

Nuveen Credit Strategies Income Fund (JQC) formed multiple bottom with $7.30 target or 9.00% below today’s $8.02 share price. Nuveen Credit Strategies Income Fund (JQC) has $1.09B valuation. The stock decreased 0.50% or $0.04 during the last trading session, reaching $8.02. About 1.13M shares traded or 51.52% up from the average. Nuveen Credit Strategies Income Fund (NYSE:JQC) has risen 8.82% since March 13, 2017 and is uptrending. It has underperformed by 7.88% the S&P500.

Among 6 analysts covering OraSure Technologies (NASDAQ:OSUR), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. OraSure Technologies had 25 analyst reports since August 6, 2015 according to SRatingsIntel. The company was maintained on Thursday, August 3 by Canaccord Genuity. The rating was maintained by Canaccord Genuity on Wednesday, August 24 with “Buy”. The rating was maintained by Canaccord Genuity with “Buy” on Monday, October 23. Jefferies maintained OraSure Technologies, Inc. (NASDAQ:OSUR) on Friday, October 20 with “Buy” rating. The stock of OraSure Technologies, Inc. (NASDAQ:OSUR) has “Buy” rating given on Wednesday, November 22 by Canaccord Genuity. Jefferies maintained the shares of OSUR in report on Thursday, August 3 with “Buy” rating. The firm has “Buy” rating given on Tuesday, September 19 by Canaccord Genuity. The company was upgraded on Thursday, February 9 by Raymond James. Jefferies maintained OraSure Technologies, Inc. (NASDAQ:OSUR) on Thursday, June 8 with “Buy” rating. BTIG Research downgraded the stock to “Neutral” rating in Monday, September 19 report. See OraSure Technologies, Inc. (NASDAQ:OSUR) latest ratings:

13/02/2018 Broker: Jefferies Rating: Hold New Target: $17.5 Maintain
02/02/2018 Broker: Canaccord Genuity Rating: Buy New Target: $24.0 Maintain
15/12/2017 Broker: Raymond James Rating: Buy
22/11/2017 Broker: Canaccord Genuity Rating: Buy New Target: $21.0 Maintain
02/11/2017 Broker: Canaccord Genuity Rating: Buy New Target: $19.0 Maintain
02/11/2017 Broker: Jefferies Old Rating: Buy New Rating: Hold Downgrade
23/10/2017 Broker: Canaccord Genuity Rating: Buy New Target: $22.0 Maintain
20/10/2017 Broker: Jefferies Rating: Buy New Target: $23.0 Maintain
19/09/2017 Broker: Canaccord Genuity Rating: Buy New Target: $22.0 Maintain

Investors sentiment decreased to 1.1 in 2017 Q3. Its down 0.33, from 1.43 in 2017Q2. It dived, as 9 investors sold Nuveen Credit Strategies Income Fund shares while 19 reduced holdings. 11 funds opened positions while 29 raised stakes. 35.27 million shares or 0.63% more from 35.05 million shares in 2017Q2 were reported. Two Sigma Securities Ltd reported 24,163 shares. Private Advisor Group Incorporated Limited Liability has 0.01% invested in Nuveen Credit Strategies Income Fund (NYSE:JQC). Thrivent Financial For Lutherans invested 0% in Nuveen Credit Strategies Income Fund (NYSE:JQC). Millennium Mgmt Ltd Liability Company holds 84,815 shares. Invesco Ltd has invested 0.01% of its portfolio in Nuveen Credit Strategies Income Fund (NYSE:JQC). The Nebraska-based Cls Invests Ltd Llc has invested 0% in Nuveen Credit Strategies Income Fund (NYSE:JQC). Mcgowan Gru Asset reported 29,030 shares. Wells Fargo Company Mn, California-based fund reported 1.19M shares. Guggenheim Cap Ltd Liability Com holds 0.02% or 1.08 million shares in its portfolio. Texas-based Next Financial Grp Inc has invested 0.01% in Nuveen Credit Strategies Income Fund (NYSE:JQC). 301,249 were reported by Dubuque Bancorporation And Trust. U S Global invested in 5,500 shares or 0.02% of the stock. Baillie Gifford And has 645,600 shares. 38,045 are owned by Bb&T Ltd Liability Corp. Eaton Vance accumulated 952,498 shares.

OraSure Technologies, Inc., together with its subsidiaries, develops, makes, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company has market cap of $1.13 billion. It operates in two divisions, OSUR and DNAG. It has a 36.33 P/E ratio. The firm also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests.

Since September 29, 2017, it had 0 insider purchases, and 4 sales for $1.87 million activity. SMITH BRIAN sold $359,460 worth of stock. $563,713 worth of stock was sold by Michels Douglas A on Friday, September 29. Another trade for 23,333 shares valued at $419,247 was sold by TANG STEPHEN S PHD.

Investors sentiment decreased to 0.83 in Q3 2017. Its down 0.18, from 1.01 in 2017Q2. It fall, as 18 investors sold OraSure Technologies, Inc. shares while 69 reduced holdings. 35 funds opened positions while 53 raised stakes. 54.93 million shares or 2.92% more from 53.38 million shares in 2017Q2 were reported. Tiaa Cref Inv Lc invested 0.01% of its portfolio in OraSure Technologies, Inc. (NASDAQ:OSUR). Moreover, Primecap Com Ca has 0.02% invested in OraSure Technologies, Inc. (NASDAQ:OSUR) for 1.26 million shares. Hillsdale Inv Mngmt owns 76,400 shares for 0.29% of their portfolio. Great West Life Assurance Can, a Manitoba – Canada-based fund reported 82,473 shares. Deutsche Bancshares Ag holds 0.01% of its portfolio in OraSure Technologies, Inc. (NASDAQ:OSUR) for 418,846 shares. Gilder Gagnon Howe And Com Limited Liability Corporation invested in 0.05% or 160,191 shares. Pub Employees Retirement Association Of Colorado reported 0% stake. North Carolina-based Natl Bank Of America De has invested 0% in OraSure Technologies, Inc. (NASDAQ:OSUR). Public Sector Pension Invest Board reported 37,496 shares stake. Wolverine Asset Mgmt Llc invested in 25,063 shares. Clarivest Asset Management Lc, a California-based fund reported 266,122 shares. Pnc Financial Ser Incorporated invested in 0% or 58,144 shares. Ny State Teachers Retirement System holds 41,995 shares or 0% of its portfolio. Usa Fincl Portformulas Corporation owns 26,876 shares. 205,714 are held by Qs.

The stock increased 1.53% or $0.28 during the last trading session, reaching $18.53. About 465,093 shares traded. OraSure Technologies, Inc. (NASDAQ:OSUR) has risen 116.07% since March 13, 2017 and is uptrending. It has outperformed by 99.37% the S&P500.